Rights and permissions
About this article
Cite this article
Surveillance not a bad option for early testicular cancer. Pharmacoecon. Outcomes News 291, 10 (2000). https://doi.org/10.1007/BF03268993
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03268993